Clinical Trial Update: Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study [Phase 2]

View source ↗

Summary

Phase 2 open-label trial assessing losartan with imaging perfusion restrictions related to extracellular solid stress in glioblastoma and brain metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Glioblastoma

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: Kyrre Eeg Emblem | Conditions: Glioblastoma, Brain Metastases | Phase 2 | Status: UNKNOWN